Xeloda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer
Condition: Gastric Cancer Interventions: Drug: RC48-ADC; Drug: Herceptin; Drug: Toripalimab; Drug: Oxaliplatin injection; Drug: Capecitabine Sponsor: RemeGen Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials

Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer
Condition: Locally Advanced Rectal Cancer Interventions: Drug: AK104; Drug: Capecitabine; Radiation: Neoadjuvant Radiotherapy Sponsors: Sun Yat-sen University; Akeso; Haplox Biotechnology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials

A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma Interventions: Drug: QL1706; Drug: Bevacizumab; Drug: Oxaliplatin injection; Drug: Capecitabine; Drug: Sintilimab Sponsor: Qilu Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2023 Category: Research Source Type: clinical trials